Connecting the Immune Response to Amyloid-β Aggregation in Alzheimer’s Disease via IFITM3

Connecting the Immune Response to Amyloid-β Aggregation in Alzheimer’s Disease via IFITM3 Reporter : Irina Robu, PhD Alzheimer’s disease is a complex condition and it begins with slow aggregation of amyloid-β deposits over the course of years. This produces a mild cognitive impairment and a state of chronic inflammation enough to trigger harmful aggregation of … Continue reading Connecting the Immune Response to Amyloid-β Aggregation in Alzheimer’s Disease via IFITM3